PRINCETON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter of fiscal year 2023.
Certara Reports Fourth Quarter 2023 Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Year Over Year Fourth Quarter Net Income Improvement of $16.4 Million and Adjusted EBITDA Growth of 89%
Continued strong cash generation and debt paydown further reduces net leverage
Provides outlook.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
28.02.2024 - Revance Therapeutics, Inc. (NASDAQ: RVNC), today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update. Financial Highlights Total revenue for the fourth quarter 2023 was $69.8 .